our mission is to improve the lives of patients by developing innovative treatments that address unmet medical needs in Biotechnological Drugs.
Our vision is to be established as a well-established Bio-pharmaceutical company in Middle east, in terms of expertise, innovation and responsible entrepreneurship
importing critical Medicines needs of Iranian market
Transferring up to date Technologies to Iran
Contract manufacturing with high tech Pharmaceutical companies
Localized Manufacturing of imported Medicines
API production and manufacturing
Technology and new drug development
Several niche product
opportunities in Dermatology,
Generic Markets in Iran
and Middle east
First to launch Biosimilar
rituximab in 2007
4 Biosimilar products
Production of APIs and Final bio-tech drugs.
Joint technology development and transfer.
Entering into new international markets and
new production line such as medical devices.
Investment and joint venture contract on
for sustained profitable
growth given our proven
capability in complex
generics with strategic
investments in R&D and
Started June 2008, but our first step was 1997 in a cooperation with pharmaceutical co.
(Department of Pharmaceutical Biotechnology , TUMS) and & ICGEB &
BTU in ICGEB , Italy.
Manufacturing Plant Main Departments
Filling and Finished products
Vials (liquid & lyophilized)
Our on-site laboratories are fully equipped to perform wide
range of physicochemical, biochemical, bioanalytical,
molecular biology and microbiology tests.
Research & Development